The company will showcase its comprehensive portfolio of biomaterials and implant systems and will offer workshops on bone regeneration and open-healing concepts in modern implant dentistry.
Basel – July 24, 2023 BioHorizons Camlog today announce that it will participate in the European Association for Osseointegration (EAO) 2023 Congress, held in Berlin from September 28 to 30, 2023. According to EAO, more than 5,000 visitors from all over the world are expected at this year's event. For the first time, it will also be possible to attend EAO programmes online, whereby all participants will be actively involved in the broadcasts and discussions.
At the BioHorizons Camlog stand H09, participants can discover the company's broad portfolio of innovative and holistic regenerative solutions in biomaterials and implant systems. BioHorizons Camlog has established itself as one of the leading suppliers of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions which helps dentists to provide patients with the optimum treatment.
BioHorizons Camlog will also host two workshops at EAO.
On Friday, September 29, 2023, Prof. Daniel Rothamel (Germany) will speak on allogeneic bone substitute materials for bone regeneration in his workshop. He will demonstrate fundamentals and techniques of hard tissue augmentation with allografts based on patient cases and hands-on exercises. The practical exercises on the model include the application of allogeneic materials in particulate form, block augmentation, and the shell technique.
Later that day, Dr. Robert Oretti (United Kingdom) will present the concept of open healing and demonstrate options for its application in modern implant dentistry. In this hands-on workshop, participants will learn to choose between the different treatment options, focusing on the steps to achieve passive closure over the bone graft without compromising the muco-gingival line.
Between the two workshops, Prof. Rothamel and Dr. Oretti will provide insight into allogeneic bone substitute materials in an industry forum, as there is growing evidence that allogeneic grafts may be a safe alternative to autologous grafts in implant therapy. In this forum, they will be presenting new data and therapeutic concepts on allografts, indicating the potential clinical relevance of these materials in implant dentistry.
About BioHorizons Camlog
BioHorizons Camlog is a leading supplier of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions. It is committed to developing evidence-based and scientifically proven products, as well as continuing education adhering to highest standards.
Headquartered in the U.S. and Europe, BioHorizons Camlog’s geographic positions allow it to efficiently serve direct subsidiaries in the Americas and Western Europe, as well as its entire distribution network in more than 90 countries around the world.
The company is part of Henry Schein, Inc., a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, Henry Schein’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.